Announcements Trials
Browse Landscape

Status

Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 2

Sponsor

Cancer Type

Lymphoid 2Gastrointestinal 2Dermatologic 2Thoracic 1Other solid neoplasm 1Other hematologic neoplasm 1Other 1

Conditions

Lymphoma 539Precursor Cell Lymphoblastic Leukemia-Lymphoma 499Lymphoma, Non-Hodgkin 435Lymphoma, Follicular 403Leukemia, Lymphocytic, Chronic, B-Cell 388Lymphoma, Large B-Cell, Diffuse 385Lymphoma, B-Cell 246Lymphoma, Mantle-Cell 222Hodgkin Disease 207Recurrence 204Leukemia, Myeloid, Acute 197Leukemia 191Multiple Myeloma 184Burkitt Lymphoma 181Lymphoma, B-Cell, Marginal Zone 170Neoplasms 151Myelodysplastic Syndromes 132Hematologic Neoplasms 115Waldenstrom Macroglobulinemia 103Lymphoma, T-Cell, Peripheral 85Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 81Lymphoma, T-Cell 81Lymphoma, T-Cell, Cutaneous 66Leukemia, Myelogenous, Chronic, BCR-ABL Positive 62Mycosis Fungoides 57Leukemia, Biphenotypic, Acute 54Breast Neoplasms 54Myeloproliferative Disorders 50Leukemia, B-Cell 50Lymphoproliferative Disorders 47

Interventions

deucravacitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Psoriasis × Lymphoid × 1 year × Clear all
NCT07256015 2025-12-01

Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy

Bristol-Myers Squibb

Recruiting
200 enrolled
Lymphoid

Lymphoma, Follicular, Psoriasis

NCT07021495 2025-08-19

SKINERGY

Leiden University Medical Center

Recruiting
840 enrolled
Lymphoid

Abscess, Chronic Urticaria, Angioedema, Dermatitis, Atopic, Eczema, Erythema, Exanthema, Mycosis Fungoides, Neoplasms, Photosensitivity Disorders, Pruritus, Psoriasis, Urticaria, Hidradenitis Suppurativa, Plaque, Amyloid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡